Novel Drug with Dexamethasone Safe in Heavily Pretreated Multiple Myeloma
Novel Drug with Dexamethasone Safe in Heavily Pretreated Multiple Myeloma The novel drug melflufen with dexamethasone was effective in treating patients with relapsed and refractory multiple myeloma who were heavily pretreated with pomalidomide (a chemotherapy drug) and/or an anti-CD38 monoclonal antibody (a substance that helps the immune system eliminate cancer cells). In this phase 2 […]
Read More